News Roundup | Egypt Ivermectin-based Study Results Are In
Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: […]
University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial
Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe […]
Rural St. Lawrence Health Care System Participates Heavily in NIH-Sponsored COVID-19 Research Programs
Rural health systems can at times have less access to advanced clinical trials than do urban systems centering on prominent […]
China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest […]
Real-World Factors Continue to Hamper Distribution and Use of Monoclonal Antibody Treatments During COVID-19 Pandemic
A recent account indicates a successful treatment involving Eli Lilly’s monoclonal antibody treatment for COVID-19, known as bamlanivimab. After receiving […]
NIH’s Therapeutic Management of Patients with COVID-19 & Some Unanswered Questions About Disturbing Chasm
The National Institutes of Health (NIH) recently updated the COVID-19 Treatment Guidelines: Therapeutic Management of Patients with COVID-19 guidelines highlighting […]
WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19
Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]
Is NIAID Exploring Human Challenge Studies as an Alternative or Complement to Large Clinical Trials?
A number of media recently reported that the National Institutes of Allergy and Infectious Diseases (NIAID) communicated that government scientists […]
ACTIV: Centralization an Important Part of COVID-19 Fight, But Smaller Players and Community Left Out
With the COVID-19 pandemic raging, the National Institutes of Health (NIH) announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) […]
